Phylomer based oligonucleotide therapy (PYC Therapeutics)

N/A

Report date: 2025/03/20 14:42:45
NME

Base Information

Drug NamePhylomer based oligonucleotide therapy (PYC Therapeutics)
Drug Alias NamePhylomer based oligonucleotide therapy (Phylogica)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPYC Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesPYC Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A